文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

多形性胶质母细胞瘤:诊断、治疗及侵袭

Glioblastoma multiforme: Diagnosis, treatment, and invasion.

作者信息

Li Jiawei, Feng Lili, Lu Yingmei

机构信息

Department of Physiology, School of Basic Medical Sciences, Nanjing Medical University, Nanjing, Jiangsu 211166, China.

The First Clinical Medical College of Nanjing Medical University, Nanjing, Jiangsu 211166, China.

出版信息

J Biomed Res. 2022 Oct 28;37(1):47-58. doi: 10.7555/JBR.36.20220156.


DOI:10.7555/JBR.36.20220156
PMID:36403983
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9898042/
Abstract

Glioblastoma multiforme (GBM) is an essentially incurable brain tumor, which has been explored for approximately a century. Nowadays, surgical resection, chemotherapy, and radiation therapy are still the standardized therapeutic options. However, due to the intrinsic invasion and metastasis features and the resistance to chemotherapy, the survival rate of glioblastoma patients remains unsatisfactory. To improve the current situation, much more research is needed to provide comprehensive knowledge of GBM. In this review, we summarize the latest updates on GBM treatment and invasion. Firstly, we review the traditional and emerging therapies that have been used for GBM treatment. Given the limited efficiency of these therapies, we further discuss the role of invasion in GBM recurrence and progression, and present current research progress on the mode and mechanisms of GBM invasion.

摘要

多形性胶质母细胞瘤(GBM)是一种基本上无法治愈的脑肿瘤,人们对其进行研究已有约一个世纪。如今,手术切除、化疗和放疗仍是标准化的治疗选择。然而,由于其固有的侵袭和转移特性以及对化疗的耐药性,胶质母细胞瘤患者的生存率仍然不尽人意。为改善当前状况,需要开展更多研究以全面了解GBM。在本综述中,我们总结了GBM治疗和侵袭方面的最新进展。首先,我们回顾了已用于GBM治疗的传统和新兴疗法。鉴于这些疗法的疗效有限,我们进一步讨论侵袭在GBM复发和进展中的作用,并介绍GBM侵袭模式和机制的当前研究进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f66/9898042/05799649fdf9/jbr-37-1-47-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f66/9898042/ed67b261671c/jbr-37-1-47-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f66/9898042/28c700da780c/jbr-37-1-47-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f66/9898042/f9b183fea52b/jbr-37-1-47-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f66/9898042/05799649fdf9/jbr-37-1-47-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f66/9898042/ed67b261671c/jbr-37-1-47-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f66/9898042/28c700da780c/jbr-37-1-47-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f66/9898042/f9b183fea52b/jbr-37-1-47-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7f66/9898042/05799649fdf9/jbr-37-1-47-4.jpg

相似文献

[1]
Glioblastoma multiforme: Diagnosis, treatment, and invasion.

J Biomed Res. 2022-10-28

[2]
A narrative review of research progress on drug therapies for glioblastoma multiforme.

Ann Transl Med. 2021-6

[3]
Mechanisms of Resistance and Current Treatment Options for Glioblastoma Multiforme (GBM).

Cancers (Basel). 2023-4-1

[4]
Environmental interplay: Stromal cells and biomaterial composition influence in the glioblastoma microenvironment.

Acta Biomater. 2021-9-15

[5]
Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.

J Neurosurg. 2015-4

[6]
The Current State of Potential Therapeutic Modalities for Glioblastoma Multiforme: A Clinical Review.

Curr Drug Metab. 2020

[7]
Nanotechnology meets glioblastoma multiforme: Emerging therapeutic strategies.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2023-1

[8]
The Role of Hypoxia in Glioblastoma Invasion.

Cells. 2017-11-22

[9]
Protective Role of Natural Products in Glioblastoma Multiforme: A Focus on Nitric Oxide Pathway.

Curr Med Chem. 2021

[10]
The Role of Kinase Signaling in Resistance to Bevacizumab Therapy for Glioblastoma Multiforme.

Cancer Biother Radiopharm. 2019-8

引用本文的文献

[1]
A PANoptosis-Based Signature for Survival and Immune Predication in Glioblastoma Multiforme.

Ann Clin Transl Neurol. 2025-7

[2]
NID2 Affects Prognosis of Glioma via Activating the Akt Signaling Pathway.

Int J Mol Sci. 2025-4-18

[3]
Expression of some circulating microRNAs as predictive biomarkers for prognosis and treatment response in glioblastoma.

Sci Rep. 2025-1-14

[4]
Advances in nano-delivery of phytochemicals for glioblastoma treatment.

Discov Nano. 2024-12-24

[5]
6-Gingerol Induced Apoptosis and Cell Cycle Arrest in Glioma Cells via MnSOD and ERK Phosphorylation Modulation.

Biomol Ther (Seoul). 2025-1-1

[6]
Inhibition of CHI3L1 decreases N-cadherin and VCAM-1 levels in glioblastoma.

Pharmacol Rep. 2025-2

[7]
Inhibition of CHI3L1 decreases N-cadherin and VCAM-1 levels in glioblastoma.

Res Sq. 2024-9-24

[8]
Emerging Insights into the PI3K/AKT/mTOR Signaling Pathway and Non-Coding RNA-mediated Drug Resistance in Glioblastoma.

Curr Mol Med. 2025

[9]
Biophysical Control of the Glioblastoma Immunosuppressive Microenvironment: Opportunities for Immunotherapy.

Bioengineering (Basel). 2024-1-18

本文引用的文献

[1]
FACTORS AFFECTING OUTCOME IN THE TREATMENT OF GLIOBLASTOMA.

Acta Clin Croat. 2022-2

[2]
Diagnosis of Glioblastoma by Immuno-Positron Emission Tomography.

Cancers (Basel). 2021-12-24

[3]
Radiotherapy for glioblastoma: clinical issues and nanotechnology strategies.

Biomater Sci. 2022-2-15

[4]
Radiation guidelines for gliomas.

Cancer Radiother. 2022

[5]
A Comparison of Epidemiological Characteristics of Central Nervous System Tumours in China and Globally from 1990 to 2019.

Neuroepidemiology. 2021

[6]
Serpin peptidase inhibitor, clade E nexin group 1 promotes cellular proliferative capacities and malignant behaviors in glioblastoma through upregulating hairy and enhancer of split-1.

J BUON. 2021

[7]
Anti-glioblastoma effects of nanomicelle-curcumin plus erlotinib.

Food Funct. 2021-11-1

[8]
Cancer Signaling Drives Cancer Metabolism: AKT and the Warburg Effect.

Cancer Res. 2021-10-1

[9]
SERPINA3 in glioblastoma and Alzheimer's disease.

Aging (Albany NY). 2021-9-29

[10]
PPFIBP1 induces glioma cell migration and invasion through FAK/Src/JNK signaling pathway.

Cell Death Dis. 2021-9-3

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索